Impaired bortezomib binding to mutant beta 5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells.

N.E. Franke, D. Niewerth, Y.G. Assaraf, J. van Meerloo, K Vojtekova, C.H. van Zantwijk, S. Zweegman, E.T. Chan, D.P. Geerke, A.D. Schimmer, G.J.L. Kaspers, G. Jansen, J. Cloos

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)757-768
Issue number4
Publication statusPublished - 2012

Cite this